Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.

CONTEXT Variation at the DAOA/G30 locus has been described to be associated with both schizophrenia and bipolar disorder, but there is little consistency between studies of the tested polymorphisms or variants showing association. OBJECTIVES To obtain a stringent replication of association in large samples of both disorders using consistent clinical and laboratory methods, and to test the hypothesis that association at DAOA/G30 identifies an underlying domain of psychopathological abnormalities that cuts across traditional diagnostic categories. DESIGN A systematic study of polymorphisms at DAOA/G30 using genetic case-control association analysis. SETTING Subjects were unrelated and ascertained from general psychiatric inpatient and outpatient services. PARTICIPANTS White persons from the United Kingdom meeting criteria for DSM-IV schizophrenia (n = 709) or bipolar I disorder (n = 706) and 1416 ethnically matched controls. METHODS Nine polymorphisms that tag common genetic variations at DAOA/G30 were genotyped in all of the individuals, and comparisons were made between affected and unaffected individuals. RESULTS We identified significant association (P = .01-.047) between 3 single-nucleotide polymorphisms and bipolar disorder but failed to find association with schizophrenia. Analyses across the traditional diagnostic categories revealed significant evidence (P = .002-.02) for association with 4 single-nucleotide polymorphisms in the subset of cases (n = 818) in which episodes of major mood disorder had occurred (gene-wide P = .009). We found a similar pattern of association in bipolar cases and in schizophrenia cases in which individuals had experienced major mood disorder. In contrast, we found no evidence for association in the subset of cases (n = 1153) in which psychotic features occurred (all P>.08). CONCLUSIONS Despite being originally described as a schizophrenia susceptibility locus, our data suggest that variation at the DAOA/G30 locus does not primarily increase susceptibility for prototypical schizophrenia or psychosis. Instead, our results imply that variation at the DAOA/G30 locus influences susceptibility to episodes of mood disorder across the traditional bipolar and schizophrenia categories.

[1]  G. Kirov,et al.  Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. , 2005, Archives of general psychiatry.

[2]  G. Kirov,et al.  Stage 2 of the Wellcome Trust UK–Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16–q21, 4q12–q21, 9p21, 10p14–p12 and 18q22 , 2006, Molecular Psychiatry.

[3]  J. Mcgrath.  Variations in the incidence of schizophrenia: data versus dogma. , 2005, Schizophrenia bulletin.

[4]  P. Skolnick,et al.  Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715) , 1995, Pharmacology Biochemistry and Behavior.

[5]  E. Gershon,et al.  Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.

[6]  S. Duan,et al.  A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population , 2005, Schizophrenia Research.

[7]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[8]  M. Owen,et al.  A systematic genomewide linkage study in 353 sib pairs with schizophrenia. , 2003, American journal of human genetics.

[9]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[10]  T. Crow.  The Continuum of Psychosis and Its Genetic Origins , 1990, British Journal of Psychiatry.

[11]  A. Chakravarti,et al.  No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families , 2005, Molecular Psychiatry.

[12]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[13]  M. Weissman,et al.  Sex differences in rates of depression: cross-national perspectives. , 1993, Journal of affective disorders.

[14]  G. Kirov,et al.  The Wellcome trust UK–Irish bipolar affective disorder sibling-pair genome screen: first stage report , 2002, Molecular Psychiatry.

[15]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[16]  M. Papp,et al.  Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. , 1994, European journal of pharmacology.

[17]  F. McMahon,et al.  Panic disorder with familial bipolar disorder , 1997, Biological Psychiatry.

[18]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[19]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[20]  S. Christian,et al.  Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. , 2003, American journal of human genetics.

[21]  P. Skolnick,et al.  Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. , 1996, Pharmacopsychiatry.

[22]  P. Skolnick,et al.  Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. , 1994, The Journal of pharmacology and experimental therapeutics.

[23]  G. Kirov,et al.  Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools , 2002, Human Genetics.

[24]  V. Hillier,et al.  The Distinction Between the Affective Psychoses and Schizophrenia , 1979, British Journal of Psychiatry.

[25]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Deanna Greenstein,et al.  Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified , 2004, Biological Psychiatry.

[27]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[28]  M. Owen,et al.  Association studies in psychiatric genetics , 1997, Molecular Psychiatry.

[29]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[30]  N. Mjellem,et al.  Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice , 1993, Neuropharmacology.

[31]  R. Murray,et al.  A comparison of the utility of dimensional and categorical representations of psychosis , 1999, Psychological Medicine.

[32]  C. Tamminga,et al.  Schizophrenia and glutamatergic transmission. , 1998, Critical reviews in neurobiology.

[33]  M. Owen,et al.  The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia , 2000, Molecular Psychiatry.

[34]  W. Berrettini.  Evidence for shared susceptibility in bipolar disorder and schizophrenia , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[35]  J. DePaulo.  Genetics of bipolar disorder: where do we stand? , 2004, The American journal of psychiatry.

[36]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[37]  M. Taylor,et al.  Are schizophrenia and affective disorder related? A selective literature review. , 1992, The American journal of psychiatry.

[38]  P. Skolnick,et al.  Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. , 1990, European journal of pharmacology.

[39]  Peter McGuffin,et al.  A twin study of genetic relationships between psychotic symptoms. , 2002, The American journal of psychiatry.

[40]  N. Craddock,et al.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis , 2005, Journal of Medical Genetics.

[41]  F. McMahon,et al.  Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33 , 2004, Molecular Psychiatry.

[42]  G. Kirov,et al.  No association between schizophrenia and polymorphisms in COMT in two large samples. , 2005, The American journal of psychiatry.

[43]  G. Kirov,et al.  The Bipolar Affective Disorder Dimension Scale (BADDS) – a dimensional scale for rating lifetime psychopathology in Bipolar spectrum disorders , 2004, BMC psychiatry.

[44]  S. Cichon,et al.  Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder , 2004, Molecular Psychiatry.

[45]  T. Brugha,et al.  SCAN. Schedules for Clinical Assessment in Neuropsychiatry. , 1990, Archives of general psychiatry.

[46]  E. Przegaliński,et al.  Antidepressant-like Effects of a Partial Agonist at Strychnine-insensitive Glycine Receptors and a Competitive NMDA Receptor Antagonist , 1997, Neuropharmacology.

[47]  S. Cichon,et al.  Investigation of the DAOA/G30 locus in panic disorder , 2005, Molecular Psychiatry.

[48]  M. Weissman,et al.  Best estimate of lifetime psychiatric diagnosis: a methodological study. , 1982, Archives of general psychiatry.

[49]  W. Danysz,et al.  Potential antidepressive properties of amantadine, memantine and bifemelane. , 1993, Pharmacology & toxicology.

[50]  D. Lancet,et al.  Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis , 2004, Biological Psychiatry.

[51]  M. Owen,et al.  A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. , 1999, Human molecular genetics.

[52]  B S Weir,et al.  Truncated product method for combining P‐values , 2002, Genetic epidemiology.

[53]  H. H. Kornhuber,et al.  Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.

[54]  Robin M. Murray,et al.  A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder , 2004, Schizophrenia Research.

[55]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[56]  A. Farmer,et al.  A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. , 1991, Archives of general psychiatry.

[57]  N. Craddock,et al.  Design of Case‐controls Studies with Unscreened Controls , 2005, Annals of human genetics.

[58]  N. Craddock,et al.  The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.

[59]  R. Murray,et al.  S36.01 A Comparison of the Utility of Dimensional and Categorical Representations of Psychosis , 2000, European Psychiatry.

[60]  C. Gambarana,et al.  Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats , 1993, Pharmacology Biochemistry and Behavior.

[61]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.